Skip to main content

Advertisement

SpringerLink
Log in

Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  • Abdalla EK (2009) Commentary: radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology. Am J Surg 197:737–739

    Article  PubMed  Google Scholar 

  • Abdalla EK, Vauthey JN (2008) Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful? Dig Surg 25:421–429

    Article  PubMed  CAS  Google Scholar 

  • Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastasis. Ann Surg 239:818–825

    Article  PubMed  Google Scholar 

  • Adam R (2003) Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 14(Suppl 2):ii13–ii16

    Google Scholar 

  • Adam R (2004) Current surgical strategies for the treatment of colorectal cancer liver metastases. Eur J Cancer Suppl 2:21–26

    Article  Google Scholar 

  • Adam R, Delvart V, Pascal G et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644–657

    Article  PubMed  Google Scholar 

  • Adam R, Aloia T, Levi F et al (2007a) Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 25:4593–4602

    Article  PubMed  CAS  Google Scholar 

  • Adam R, Miller R, Pitombo M et al (2007b) Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 16:525–536

    Article  PubMed  Google Scholar 

  • Adam R, Wicherts DA, de Haas RJ et al (2008) Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26:1635–1641

    Article  PubMed  Google Scholar 

  • Alberts SR, Wagman LD (2008) Chemotherapy for colorectal cancer liver metastases. Oncologist 13:1063–1073

    Article  PubMed  Google Scholar 

  • Aloia T, Sebagh M, Plasse M et al (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983–4990

    Article  PubMed  CAS  Google Scholar 

  • Amado RG, Wolf M, Peeters M et al (2008) Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 26:1626–1634

    Article  PubMed  CAS  Google Scholar 

  • Andre L, Boni C, Navarro M et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovourin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109–3116

    Article  PubMed  CAS  Google Scholar 

  • Antonion A, Lovegrove RE, Tilney HS et al (2007) Meta analysis of clinical outcome after first and second liver resection for colorectal metastases. Surgery 141:9–18

    Article  Google Scholar 

  • Arru M, Aldrighetti L, Castoldi R et al (2008) Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg 32:93–103

    Article  PubMed  Google Scholar 

  • Benoist S, Nordlinger B (2007) Neoadjuvant treatment before resection of liver metastases. Eur J Surg Oncol 33(Suppl 2):S35–4S1

    Google Scholar 

  • Benoist S, Nordlinger B (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16:2385–2390

    Article  PubMed  Google Scholar 

  • Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945

    Article  PubMed  Google Scholar 

  • Bentrem DJ, DeMatteo RP, Blumgart LH (2005) Surgical therapy for metastatic disease to the liver. Ann Rev Med 56:139–156

    Article  PubMed  CAS  Google Scholar 

  • Berber E, Tsinberg M, Tellioglu G et al (2008) Resection versus laparoscopic radio frequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg 12:1967–1972

    Article  PubMed  Google Scholar 

  • Bilchik AJ, Wood TF, Allegra DP (2001) Radiofrequency ablation of unresectable hepatic malignancies: lesson learned. Oncologist 6:24–33

    Article  PubMed  CAS  Google Scholar 

  • Bipat S, van Leeuwen MS, Ijzermans JN et al (2007) Evidence-base guideline on management of colorectal liver metastases in the Netherlands. Neth J Med 65:5–14

    PubMed  CAS  Google Scholar 

  • Blatzer D, Kishi Y, Maru DM et al (2008) Pathologic response to preoperative chemotherapy: a new outcome end poin after resection of hepatic colorectal metastases. J Clin Oncol 17:5299

    Google Scholar 

  • Bokemeyer C, Bandarenko I, Mahkson A et al (2009) Fluorouracil leucovorin and oxaliplatin with or without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 27:663–671

    Article  PubMed  CAS  Google Scholar 

  • Borschitz T, Wachtlin D, Möhler M et al (2008) Junginger T.Neoadjuvant chemoradiation and local excision for T2–3 rectal cancer. Ann Surg Oncol 15:712–720

    Article  PubMed  Google Scholar 

  • Bouganim N, Ang C, Kavan P et al (2008) Perioperative bevacizumab containing chemotherapy for colorectal liver metastases. J Clin Oncol 26: abstr 15073

  • Cals L, Rixe O, Francois E et al (2004) Dose-finding study of weekly 24 h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients. Ann Oncol 15:1018–1024

    Article  PubMed  CAS  Google Scholar 

  • Capussotti L, Ferrero A, Vigano L et al (2007) Major liver resection synchronous with colorectal surgery. Ann Surg Oncol 14:195–201

    Article  PubMed  Google Scholar 

  • Carpizo DR, D’Angelica M (2009) Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Ann Surg Oncol 16:2411–2421

    Article  PubMed  Google Scholar 

  • Cassidy J, Clarke s, Diaz-Rubio D et al (2007) XELOX vs. FOLFOX4: efficacy results from XELOX-1/NO16966, a randomized phase III trial in first-line metastatic colorectal cancer. In: 2007 gastrointestinal cancers symposium. Abstract 270

  • Cassidy J, Cunningham D, Berry SR et al (2008) Surgery with curative intent in patients treated with first-line chemotherapy + bevacizumab for metastatic colorectal cancer: first BEAT and NO16966. J Clin Oncol 26(Suppl):4022

    Google Scholar 

  • Ceelen WP, van Nieuwenhove Y, Fierens K (2009) Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer (Review). Cochrane Database Syst Rev (1):CD006041

  • Cervantes A, Roselló S, Rodríguez-Braun E et al (2008) Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer. Ann Oncol 19(Suppl 7):vii266–272

    Google Scholar 

  • Chau I, Chan S, Cunningham D (2003) Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectives. Clin colorectal Cancer 3:19–33

    Article  PubMed  Google Scholar 

  • Chiappa A, Bertani E, Makuuchi M et al (2009) Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases. Hepatogastroenterology 56(91–92):829–834

    PubMed  Google Scholar 

  • Choti MA (2009) Chemotherapy-associated hepatotoxicity: do we need to be concerned? Ann Surg Oncol 16:2391–2394

    Article  PubMed  Google Scholar 

  • Clancy TE, Dixon E, Perlis R et al (2005) Hepatic arterial infusion after curative resection of colorectal cancer metastases: a meta-analysis of prospective clinical trials. J Gastrointest Surg 9:198–206

    Article  PubMed  Google Scholar 

  • Cleary JM, Tanabe KT, Lauwers GY et al (2009) Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver. Oncologist 14:1095–1105

    Article  PubMed  Google Scholar 

  • Coenegrachts K, De Geeter F, ter Beek L et al (2009) Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol 19:370–379

    Article  PubMed  Google Scholar 

  • Colucci G, Gebbia V, Paoletti G et al (2005) Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale. J Clin Oncol 23:4866–4875

    Article  PubMed  CAS  Google Scholar 

  • Coskun U, Buyukberber S, Yaman E et al (2008) Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients. Neoplasma 55:65–70

    PubMed  CAS  Google Scholar 

  • Covey AM, Brown KT, Jamagin WR et al (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247:451–455

    Article  PubMed  Google Scholar 

  • Cunningham D, Humblet Y, Siena S et al (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337–345

    Article  PubMed  CAS  Google Scholar 

  • Curley SA, Izzo F (2002) Radiofrequency ablation of hepatocellular carcinoma. Minerva Chir 57:165–176

    PubMed  CAS  Google Scholar 

  • D’Angelica M, Kornprat P, Gonen M et al (2007) Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol 14:759–765

    Article  PubMed  Google Scholar 

  • De Gramout A, Boni C, Navarro M et al (2007) Oxaliplatin/5-FU/LV in adjuvant colon cancer: updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of 6 years. J Clin Oncol 25:18S (June 20 suppl). Abstract 4007

    Google Scholar 

  • De Jong MC, Pulitano C, Ribero D et al (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250:440–448

    PubMed  Google Scholar 

  • De Roock W, Piessevaux H, De Schutter J et al (2008) KRAS wild-type state predicts survival and is associated to early radiological response in metastastic colorectal cancer treated with cetuximab. Ann Oncol 19:508–515

    Article  PubMed  Google Scholar 

  • Delbeke D, Martin WH (2004) PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med 34:209–223

    Article  PubMed  Google Scholar 

  • Desch CE, Benson AB, Somerfield MR et al (2005) Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23:8512–8519

    Article  PubMed  Google Scholar 

  • Di Stefano DR, de Baere T, Denys A et al (2005) Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234:625–630

    Article  PubMed  Google Scholar 

  • Díaz Rubio E, Tabernero J, van Cutsem E et al (2005) Cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer: an international phase II study. J Clin Oncol 23(16 suppl):254s

    Google Scholar 

  • Eble MJ, Gademann G, Wannenmacher M et al (1993) The value of radiotherapy for liver metastases. Strahlenther-Onkol 169:459–468

    PubMed  CAS  Google Scholar 

  • Elias D, Youssef O, Sideris L et al (2004a) Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 86:4–9

    Article  PubMed  Google Scholar 

  • Elias D, Youssef O, Sideris L et al (2004b) Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 86:4–9

    Article  PubMed  Google Scholar 

  • Elias D, Liberale G, Vernerey D et al (2005) Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12:900–909

    Article  PubMed  Google Scholar 

  • Elias D, Benizri E, Pocard M et al (2006a) Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 32:632–636

    Article  PubMed  CAS  Google Scholar 

  • Elias D, Di Pietroantonio D, Gachot B et al (2006b) Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure. Gastroenterol Clin Biol 30:823–827

    Article  PubMed  Google Scholar 

  • Ellis LM, Curley SA, Grothey A (2005) Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 23:4853–4855

    Article  PubMed  CAS  Google Scholar 

  • Fahy BN, D’Angelica M, DeMatteo RP et al (2009) Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention. Ann Surg Oncol 16:361–370

    Article  PubMed  Google Scholar 

  • Falcone A, Ricci S, Brunetti I et al (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as frst-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25:1670–1676

    Article  PubMed  CAS  Google Scholar 

  • Fernandez FG, Ritter J, Goodwin JW et al (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845–853

    Article  PubMed  Google Scholar 

  • Folprecht G, Gruenberger T, Bechstein WO et al (2009) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. Nov 24 [Epub ahead of print]

  • Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938–946

    PubMed  CAS  Google Scholar 

  • Foster JH (1984) Treatment of metastatic disease of the liver: a skeptic’s view. Semin Liver Dis 4:170–179

    Article  PubMed  CAS  Google Scholar 

  • Fraker DL, Soulen M (2002) Regional therapy of hepatic metastases. Hematol Oncol Clin North Am 16:947–967

    Article  PubMed  Google Scholar 

  • Giuliante F, Ardito F, Vellone M et al (2009) Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases. J Surg Oncol 100:538–545

    Article  PubMed  Google Scholar 

  • Goldberg RM (2006) Therapy for metastatic colorectal cancer. Oncologist 11:981–987

    Article  PubMed  CAS  Google Scholar 

  • Goldberg RM, Sargent DJ, Morton RF et al (2006) Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial. J Clin Oncol 24:3347–3353

    Google Scholar 

  • Gomez D, Malik HZ, Bonney GK et al (2007) Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 94:1395–1402

    Article  PubMed  CAS  Google Scholar 

  • Goodman KA, Wiegner EA, Maturen KE et al (2010) Dose escalation study of single fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78:486–493

    Article  PubMed  Google Scholar 

  • Grothey A, Sugrue MM, Purdie DM et al (2008) Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE). J Clin Oncol 26(33):5326–5334

    Article  PubMed  CAS  Google Scholar 

  • Gruenberger B, Tamandl D, Puhalla H et al (2007) Bevacizumab plus XELOX as neoadjuvant chemotherapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 25(18 suppl):179s

    Google Scholar 

  • Gruenberger B, Scheithauer W, Punzengruber R et al (2008a) Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer 8:120

    Article  PubMed  CAS  Google Scholar 

  • Gruenberger B, Tamandl D, Schueller J et al (2008b) Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 26:1830–1835

    Article  PubMed  CAS  Google Scholar 

  • Gruenberger T, Kaczirek K, Bergmann M et al (2008) Progression-free survival in a phase II study of perioperative bevacizumab plus XELOX in patients with potentially curable metastatic colorectal cancer. J Clin Oncol 26: abstr 4073

  • Hao CY, Ji JF (2006) Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006. Eur J Surg Oncol 32:473–483

    Article  PubMed  CAS  Google Scholar 

  • Hecht JR, Mitchell E, Chidiac CJ et al (2009) A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy ang bevacizaumab alone for metastatic colorectal cancer. J Clin Oncol 27:672–680

    Article  PubMed  CAS  Google Scholar 

  • Hochster H, Hart LL, Ramanathan R et al (2006) Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE study. J Clin Oncol 24:N0. 18S (June 20 suppl). Abstract 3510

    Google Scholar 

  • Hochster HS, Hart LL, Ramanathan RK et al (2008) Safety and effcacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. J Clin Oncol 26:3523–3529

    Article  PubMed  CAS  Google Scholar 

  • Hoff PM, Eng C, Adinin RB et al (2006) Preliminary results from a phase II study of FOLFIRI plus bevacizumab as first-linetreatment for metastatic colorectal cancer (mCRC). ASCO Ann Meeting Proc 24(Suppl):165S

    Google Scholar 

  • Homayounfar K, Liersch T, Schuetze G et al (2009) Two-stage hepatectomy (R0) with portal vein ligation–towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis 24:409–418

    Article  PubMed  CAS  Google Scholar 

  • Huang K, Haas-Kogan D, Weinberg V et al (2001) Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J Gastroenterol 13:895–900

    Google Scholar 

  • Hur H, Ko YT, Min BS et al (2009) Comparative study of reseaction and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 197:728–736

    Article  PubMed  Google Scholar 

  • Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342

    Article  PubMed  CAS  Google Scholar 

  • Hurwitz HI, Fehrenbacher L, Hainsworth JD et al (2005) Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23:3502–3508

    Article  PubMed  CAS  Google Scholar 

  • Jaeck D (2003) The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 10:1007–1011

    Article  PubMed  Google Scholar 

  • Jaeck D, Oussoultzoglou E, Rosso E (2007) Hepatectomy for colorectal metastases in the presence of extrahepatic disease. Surg Oncol Clin N Am 16:507–523

    Article  PubMed  Google Scholar 

  • Johal BS, Phang P, McGahan C et al (2007) Treatment patterns and outcomes of patients with pT3N0 rectal cancer in a population-based setting. J Clin Oncol 25:No 18S(June 20 suppl). Abstract 4039

  • Jones OM, Rees M, John TG et al (2005) Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg 92:1165–1168

    Article  PubMed  CAS  Google Scholar 

  • Kabbinavar FF, Schulz J, McCleod M et al (2005a) Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23:3697–3705

    Article  PubMed  CAS  Google Scholar 

  • Kabbinavar FF, Hambleton J, Mass RD et al (2005b) Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23:3706–3712

    Article  PubMed  CAS  Google Scholar 

  • Kabbinavar FF, Hurwitz HI, Yi J et al (2009) Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials. J Clin Oncol 27:199–205

    Article  PubMed  CAS  Google Scholar 

  • Kandutsch S, Klinger M, Hacker S et al (2008) Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur J Surg Oncol 34:1231–1236

    PubMed  CAS  Google Scholar 

  • Karapetis CS, Khambata-Ford S, Jonker DJ et al (2009) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359:1757–1765

    Article  Google Scholar 

  • Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal livermetastases. Ann Surg 243:1–7

    Article  PubMed  Google Scholar 

  • Kemeny N (2006) Management of liver metastases from colorectal cancer. Oncology (Williston Park) 20:1161–1176, 1179; discussion 1179–1180, 1185–1166

  • Kemeny N, Jarnagin W, Paty P et al (2005a) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23:4888–4896

    Article  PubMed  CAS  Google Scholar 

  • Kemeny N, Eid A, Stockman J et al (2005b) Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 91:97–101

    Article  PubMed  CAS  Google Scholar 

  • Kemeny NE, Capanu M, Fong Y et al (2008) Survival after resection of liver metastases from colorectal cancer with poor clinical risk factors using adjuvant systemic plus hepatic arterial therapy. J Clin Oncol 26: abstr 4076

  • Kesmodel SB, Ellis LM, Lin E et al (2008) Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 26:5254–5260

    Article  PubMed  Google Scholar 

  • Klautke G, Fietkau R (2007) Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: a review. Int J Colorectal Dis 22:457–465

    Article  PubMed  Google Scholar 

  • Klinger M, Eipeldauer S, Hacker S et al (2009) Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol 35:515–520

    PubMed  CAS  Google Scholar 

  • Knudsen AR, Kannerup AS, Mortensen FV et al (2009) Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy. Acta Radiol 50:716–721

    Article  PubMed  Google Scholar 

  • Koshariya M, Jagad RB, Kawamoto J et al (2007) An update and our experience with metastatic liver disease. Hepatogastroenterology 54:2232–2239

    PubMed  Google Scholar 

  • Kuehl H, Antoch G, Stergar H et al (2008) Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results. Eur J Radiol 67:362–371

    Article  PubMed  Google Scholar 

  • Lau WY, Lai EC (2007) Hepatic resection for colorectal liver metastases. Singapore Med J 48:635–639

    PubMed  CAS  Google Scholar 

  • LeCouter J, Moritz DR, Li B et al (2003) Angiogenesis-independent endothelial protection of liver: role of VEGFR1. Science 299:890–893

    Article  PubMed  CAS  Google Scholar 

  • Leonard GD, Brenner B, Kemeny NE (2005) Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23:2038–2048

    Article  PubMed  CAS  Google Scholar 

  • Lochan SA, White DM, Manas (2007) Liver resection for colorectal liver metastasis. Surg Oncol 16:33–45

    Article  PubMed  CAS  Google Scholar 

  • Locker GY, Hamiton S, Harris J et al (2006) ASCO 2006 update of recommendations for use of tumor markers in gastrointestinal cancer. J Clin Oncol 24:5313–5327

    Article  PubMed  CAS  Google Scholar 

  • Lu DS, Raman SS, Limanond P et al (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14:1267–1274

    PubMed  Google Scholar 

  • Malik HZ, Farid S, Al-Mukthar A et al (2007) A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. Ann Surg Oncol 12:3519–3526

    Article  Google Scholar 

  • Masi G, Loupakis F, Pollina L et al (2009) Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg 249:420–425

    Article  PubMed  Google Scholar 

  • Mehta NN, Ravikumar R, Coldham CA et al (2008) Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34:782–786

    PubMed  CAS  Google Scholar 

  • Mentha G, Majno PE, Andres A et al (2006) Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 93:872–878

    Article  PubMed  CAS  Google Scholar 

  • Mentha G, Majno P, Terraz S et al (2007) Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. Eur J Surg Oncol 33(Suppl 2):S76–S83

    PubMed  Google Scholar 

  • Miller G, Biernacki P, Kemeny NE et al (2007) Outcomes after resection of synchronous or metachronous hepatic and pulmonary metastases. J Am Coll Surg 205:231–238

    Article  PubMed  Google Scholar 

  • Mocellin S, Pilati P, Lise M et al (2007) Hepatic arterial infusion (HAI) compared to systemic chemotherapy for the treatment of unresectable livermetastases from colorectal carcinoma: a systematic review and meta-analysis of randomized controlled trials. J Clin Oncol 25(18 suppl):626 s

    Google Scholar 

  • Mocellin S, Pasquali S, Nitti D (2009) Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. Cochrane Database Syst Rev 4:CD007823

    Google Scholar 

  • Mohiuddin M, Chen E, Ahmad N (1996) Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 14:722–728

    PubMed  CAS  Google Scholar 

  • Moug SJ, Horgan PG (2007) The role of synchronous procedures in the treatment of colorectal liver metastases. Surg Oncol 16:53–58

    Article  PubMed  Google Scholar 

  • Nakano H, Oussultzoglou E, Rosso E et al (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal metastases receiving preoperative chemotherapy. Ann Surg 247:118–124

    Article  PubMed  Google Scholar 

  • Neeleman N, Andersson R (1996) Repeated liver resection for recurrent cancer. Br J Surg 83:893–901

    Article  PubMed  CAS  Google Scholar 

  • Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262

    Article  PubMed  CAS  Google Scholar 

  • Nordlinger B, Sorbye H, Collette L et al (2007) Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of perioperative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol 5(Suppl. 18):LBA5

    Google Scholar 

  • Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007–1016

    Article  PubMed  CAS  Google Scholar 

  • Nordlinger B, Van Cutsem E, Gruenberger T et al (2009) Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 20:985–992

    Article  PubMed  CAS  Google Scholar 

  • Okuno k (2007) Surgical treatment for digestive cancer. Current issues–colon cancer. Dig Surg 24(2):108–114

    Article  PubMed  Google Scholar 

  • Otchy D, Hyman NH, Simmang C et al (2004) Practice parameters for colon cancer. Dis Colon Rectum 47:1269–1284

    Article  PubMed  Google Scholar 

  • Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722

    Article  PubMed  Google Scholar 

  • Pawlik TM, Olino K, Gleisner AL et al (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11:860–868

    Article  PubMed  Google Scholar 

  • Peeters KCMJ, Marijinen CAM, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years. Ann Surg 246:693–701

    Article  PubMed  Google Scholar 

  • Pelosi E, Deandreis D (2007) The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer. Eur J Surg Oncol 33:1–6

    PubMed  CAS  Google Scholar 

  • Poultsides GA, Servais EL, Saltz LB et al (2009) Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27:3379–3384

    Article  PubMed  Google Scholar 

  • Raoul JL, Van Laethem JL, Peeters M et al (2009) Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study. BMC Cancer 9:112

    Article  PubMed  CAS  Google Scholar 

  • Reddy SK, Morse MA, Hurwitz HI et al (2008) Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. J Am Coll Surg 206:96–106

    Article  PubMed  Google Scholar 

  • Reddy SK, Barbas AS, Clary BM (2009) Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol 16:2395–2410

    Article  PubMed  Google Scholar 

  • Reuter NP, Woodall CE, Scoggins CR et al (2009) Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivaient? J Gastrointest Surg 13:486–491

    Article  PubMed  Google Scholar 

  • Rex Dk, Kahi CJ, Levin B et al (2006) Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on colorectal cancer. CA Cancer J Clin 56:160–167; quiz 185–166

  • Robertson JM, McGinn CJ, Walker S et al (1997) A phase l trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. J Rad Oncol Biol Phys 39:1087–1092

    Article  CAS  Google Scholar 

  • Rodriguez-Moranta F, Salo J, Arcusa A et al (2006) Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 24:386–393

    Article  PubMed  Google Scholar 

  • Roohipour R, Patil S, Goodman KA et al (2008) Squamous-cell carcinoma of the canal: predictors of treatmant outcome. Dis Colon Rectum 51:147–153

    Article  PubMed  Google Scholar 

  • Rubbia-Brandt L, Giostra E, Brezault C et al (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by liver surgery. Ann Oncol 18:299–304

    Article  PubMed  CAS  Google Scholar 

  • Rusthoven KE, Kavanagh BD, Cardenes H et al (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27:1572–1578

    Article  PubMed  Google Scholar 

  • Saltz LB, Clarke S, Díaz-Rubio E et al (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26:2013–2019

    Article  PubMed  CAS  Google Scholar 

  • Samantas E, Dervenis C, Rigatos SK (2007) Adjuvant chemotherapy for colon cancer: evidence on improvement in survival. Dig Dis 25:67–75

    Article  PubMed  CAS  Google Scholar 

  • Sargent D, Sobrero A, Grothey A et al (2009) Evidence for cure by adjuvant therapy in colon cancer: obeservations based on indiviual patient data from 20, 898 patients on 18 randomized trials. J Clin Oncol 27:872–877

    Article  PubMed  Google Scholar 

  • Sarpel U, Bonavia AS, Grucela A et al (2009) Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol 16:379–384

    Article  PubMed  Google Scholar 

  • Scappaticci FA, Fehrenbacher L, Cartwright T et al (2005) Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol 91:173–180

    Article  PubMed  CAS  Google Scholar 

  • Schefter TE, Kavanagh BD, Timmerman RD et al (2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62:1371–1378

    Article  PubMed  Google Scholar 

  • Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Prooperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a muticentre, randomised trial. Lancet 373:811–820

    Article  PubMed  Google Scholar 

  • Sharma S, Camci C, Jabbour N (2008) Management of hepatic metastasis from colorectal cancers: an update. J Hepatobiliary Pancreat Surg 15:570–580

    Article  PubMed  Google Scholar 

  • Shimada H, Tanaka K, Endou I et al (2009) Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg 394:973–983

    Article  PubMed  Google Scholar 

  • Shoup M, Gonen MD, Angelica M et al (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7:325–330

    Article  PubMed  Google Scholar 

  • Siegel R, Burock S, Wernecke KD et al (2009) Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer 9:50

    Article  PubMed  CAS  Google Scholar 

  • Siperstein AE, Barber E, Ballem N, Parikh T (2007) Survival after radiofrequency ablation of colorectal liver metastases—10 year experience. Ann Surg 246:559–567

    Article  PubMed  Google Scholar 

  • Slupski M, Wlodarczyk Z, Jasinski M et al (2009) Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases. Can J Surg 52:E241–E244

    PubMed  Google Scholar 

  • Souglakos J, Androulakis N, Syrigos K et al (2006) FOLFOXIRI vs FOLFIRI as first-line treatment in metastatic colorectal cancer: a multicentre randomised phase III trial from the Hellenic Oncology Research Group. Br J Cancer 94:798–805

    Article  PubMed  CAS  Google Scholar 

  • Soumarova R, Skrovina M, Bartos J et al (2009) Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum—Toxicity and complications of the treatment. Eur J Surg Oncol Oct 29. [Epub ahead of print]

  • Tan BR, Zubal B, Hawkins W et al (2009) Preoperative FOLFOX pius cetuximab or panitumumab therapy for patients with potentially resectable hepatic colorectal metastases. In: gastrointestinal cancers symposium. Abstract 497

  • Tanaka K, Adam R, Shimada H et al (2003) Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90:963–969

    Article  PubMed  CAS  Google Scholar 

  • Tanaka K, Shimada H, Matsuo M et al (2007) Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 33:329–335

    PubMed  CAS  Google Scholar 

  • Taniai N, Akimaru K, Yoshida H, Tajiri T (2007) Surgical treatment for better prognosis of patients with liver metastases from colorectal cancer. Hepatogastroenterology 54:1805–1809

    PubMed  Google Scholar 

  • Tejpar S, Peeters M, Humblet Y et al (2008) Relationship of efficacy with KRAS status (wild type versus mutant) in patients with irinotecan-refractory metastatic colorectal cancer, treated with irinotecan and escalating doses of cetuximab: the EVERSET experience (preliminary data). J Clin Oncol 26(may 20 suppl): Abstract 4001

    Google Scholar 

  • Timmerman RD, Bizekis CS, Pass HI et al (2009) Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 59:145–170

    Article  PubMed  Google Scholar 

  • Tol J, Koopman M, Cats A et al (2009) Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 360:563–572

    Article  PubMed  CAS  Google Scholar 

  • Tomlinson JS, Jarnagin WR, DeMatteo RP et al (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575–4580

    Article  PubMed  Google Scholar 

  • Tournigand C, Andre T, Acille E et al (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GEROR study. J Clin Oncol 22:229–237

    Article  PubMed  CAS  Google Scholar 

  • Turrini O, Viret F, Guiramand J et al (2007) Strategies for the treatment of synchronous liver metastasis. Eur J Surg Oncol 33:735–740

    PubMed  CAS  Google Scholar 

  • Tveit KM, Wiig JN, Olsen DR et al (1997) Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer. Radiother Oncol 44:277–282

    Article  PubMed  CAS  Google Scholar 

  • Vadeyar HJ (2007) Current therapeutic options for colorectal liver metastases. Indian J Gastroenterol 26:26–29

    PubMed  CAS  Google Scholar 

  • Van Cutsem E, Köhne CH, Hitre E et al (2009a) Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360:1408–1417

    Article  PubMed  Google Scholar 

  • Van Cutsem E, Rivera F, Berry S et al (2009b) Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 20:1842–1847

    Article  PubMed  Google Scholar 

  • Van den Eynde M, Hendlisz A (2009) Treatment of colorectal liver metastases: a review. Rev Recent Clin Trials 4(1):56–62

    Article  PubMed  Google Scholar 

  • Van der Voort van Zijp J, Hoekstra HJ, Basson MD (2008) Evolving management of colorectal cancer. World J Gastroenterol 14:3956–3967

    Google Scholar 

  • Vauthey JN, Zorzi D, Pawlik TM (2005) Making unresectable hepatic colorectal metastases resectable–does it work? Semin Oncol 32(Suppl 9):S118–S122

    Article  PubMed  Google Scholar 

  • Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072

    Article  PubMed  CAS  Google Scholar 

  • Venook A, Hollis D et al (2006) Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin (FOLFOX) cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results. J Clin Oncol 24(18 suppl):148s

    Google Scholar 

  • Vermaas M, Gosselink MP, Ferenschild FTJ et al (2007) Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands. Eur J Surg Oncol 33:862–867

    PubMed  CAS  Google Scholar 

  • Vibert E, Canedo L, Adam R (2005) Strategies to treat primary unresectable colorectal liver metastases. Semin Oncol 32(6 suppl 8):33–39

    Article  PubMed  Google Scholar 

  • Warwick R, Page R (2007) Resection of pulmonary metastases from colorectal carcinoma. Eur J Surg Oncol 33:S59–S63

    PubMed  Google Scholar 

  • Weber JC, Bachellier P, Oussoultzoglow E et al (2003) Simultaneous resection of colorectal primary tumor and synchronous liver metastases. Br J Surg 90:956

    Article  PubMed  CAS  Google Scholar 

  • Welch S, Spithoff K, Rumble RB et al (2009) Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review. Ann Oncol [Epub ahead of print]

  • Welsh FK, Tilney HS, Tekkis PP et al (2007) Safe liver resection following chemotherapy for colorectalmetastases is amatter of timing. Br J Cancer 96:1037–1042

    Article  PubMed  CAS  Google Scholar 

  • Wolpin BM, Mayer RJ (2008) Systemic treatment of colorectal cancer. Gastroenterology 134(5):1296–1310

    Article  PubMed  CAS  Google Scholar 

  • Xu J, Zhong Y, Niu W et al (2007) Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery. Ann Surg 245:583–590

    Article  PubMed  Google Scholar 

  • Yan TD, Padang R, Xia H et al (2006) Management of involved or close resection margins in 120 patients with colorectal liver metastases: edge cryotherapy can achieve longterm survival. Am J Surg 191:735–742

    Article  PubMed  Google Scholar 

  • Ychou M, Hohenberger W, Thezenas S et al (2008) Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU + irinotecan (LV5FU + IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). J Clin Oncol 26: abstr LBA4013

  • Yu T-K, Bhosale PR, Crane CH et al (2008) Patterns of locaregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Rad Oncol Biol Phys 71:1175–1180

    Article  Google Scholar 

  • Zelck L, Bugat R, Cherqui D et al (2003) Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in nonresectable hepatic metastases from colorectal cancer. Ann Oncol 14:1537–1542

    Article  Google Scholar 

  • Zorzi D, Kishi Y, Maru DM et al (2009) Effect of extended preoperative chemotherapy on pathologic response and postoperative liver insufficiency after hepatic resection for colorectal liver metastases. J Clin Oncol; Abstract 295

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Zhongshan Hospital, Fudan University, Shanghai, China

    Jianmin Xu, Xinyu Qin, Yunshi Zhong, Li Ren, Ye Wei & Shaochong Zeng

  2. No. 6 Hospital, Zhongshan University, Guangzhou, China

    Jianping Wang

  3. No. 2 Hospital, Zhejiang Medical, Hangzhou, China

    Suzhan Zhang & Shu Zheng

  4. Tumor Hospital, Zhongshan University, Guangzhou, China

    Deseng Wan

Authors
  1. Jianmin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xinyu Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jianping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suzhan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yunshi Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ye Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shaochong Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Deseng Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shu Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xinyu Qin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, J., Qin, X., Wang, J. et al. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol 137, 1379–1396 (2011). https://doi.org/10.1007/s00432-011-0999-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-011-0999-8

Keywords

Search

Navigation